ResMed Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+10.1% +$31M
$340M
Free Cash Flow↑+8.1% +$23M
$311M
Investing Cash Flow↓-2550.0% -$55M
$-53M
Financing Cash Flow↓-52.7% -$80M
$-230M
Capex↑+38.2% +$8M
$29M
Acquisitions↓-100.0% -$670K
$0
Stock Buybacks↑+133.4% +$100M
$175M
Dividends Paid↑+12.7% +$10M
$88M
Stock-Based Comp↑+27.9% +$6M
$29M
Debt Issued
$0
Debt Repaid↑+0.0% +$0
$5M
D&A↑+7.4% +$3M
$50M
SBC Allocated Expense↑+27.9% +$6M
$29M
SBC Unrecognized Cost↑+35.3% +$21M
$82M